Ever Source Wealth Advisors, LLC Vir Biotechnology, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 1,548 shares of VIR stock, worth $9,705. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,548
Previous 311
397.75%
Holding current value
$9,705
Previous $2,000
250.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VIR
# of Institutions
247Shares Held
109MCall Options Held
350KPut Options Held
150K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$105 Million0.67% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$82.9 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL12.9MShares$81 Million34.47% of portfolio
-
State Street Corp Boston, MA5.25MShares$32.9 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $832M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...